CALISTOGA PHARMACEUTICALS INC has a total of 14 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), China and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are MOTAC NEUROSCIENCE LTD, ObsEva SA and ZAGORII GLEB VLADIMIROVICH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | China | 4 | |
#3 | Canada | 2 | |
#4 | Australia | 1 | |
#5 | Israel | 1 | |
#6 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Ulrich Roger G | 7 |
#2 | Evarts Jerry B | 5 |
#3 | Giese Neill A | 4 |
#4 | Lannutti Brian | 3 |
#5 | Giese Neill | 3 |
#6 | Gallatin Michael W | 3 |
#7 | Puri Kamal D | 3 |
#8 | Miller Langdon | 2 |
#9 | Webb Heather | 2 |
#10 | Gallatin W Michael | 1 |
Publication | Filing date | Title |
---|---|---|
AU2011265258A1 | Methods of treating hematological disorders with quinazolinone compounds in selected patients | |
CN102439012A | Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use | |
CN102271683B | Therapies for hematologic malignancies |